CELEX: 62020TA0636
Language: en
Date: 2021-10-06 00:00:00
Title: Case T-636/20: Judgment of the General Court of 6 October 2021 — Dermavita Company v EUIPO — Allergan Holdings France (JUVÉDERM VOLUMA) (EU trade mark — Invalidity proceedings — EU word mark JUVÉDERM VOLUMA — Late payment of the appeal fee — Inadmissibility of the appeal before the Board of Appeal — Article 101(4) of Regulation (EU) 2017/1001 — Article 106(1)(b) of Regulation 2017/1001 — Restitutio in integrum)

29.11.2021   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 481/27
            
         
      Judgment of the General Court of 6 October 2021 — Dermavita Company v EUIPO — Allergan Holdings France (JUVÉDERM VOLUMA)
      (Case T-636/20) (1)
      
      (EU trade mark - Invalidity proceedings - EU word mark JUVÉDERM VOLUMA - Late payment of the appeal fee - Inadmissibility of the appeal before the Board of Appeal - Article 101(4) of Regulation (EU) 2017/1001 - Article 106(1)(b) of Regulation 2017/1001 - Restitutio in integrum)
      (2021/C 481/39)
      Language of the case: English
      
         Parties
      
      
         Applicant: Dermavita Company S.a.r.l. (Beirut, Lebanon) (represented by: D. Todorov, lawyer)
      
         Defendant: European Union Intellectual Property Office (represented by: E. Markakis and V. Ruzek, acting as Agents)
      
         Other party to the proceedings before the Board of Appeal of EUIPO: Allergan Holdings France SAS (Courbevoie, France)
      
         Re:
      
      Action brought against the decision of the Fourth Board of Appeal of EUIPO of 24 August 2020 (Case R 1016/2020-4), relating to invalidity proceedings between Dermavita Company and Allergan Holdings France.
      
         Operative part of the judgment
      
      The Court:
      
                  1.
               
               
                  Dismisses the action;
               
            
                  2.
               
               
                  Orders Dermavita Company S.a.r.l. to pay the costs.
               
            
         (1)  OJ C 443, 21.12.2020.